CompaniesCalvert Laboratories

Calvert Laboratories

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

295

By Phase

PHASE4: 2

By Status

COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details

Recent Trials

NCT06991348Lead Sponsor
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
PHASE4Recruiting
128 participants
Started: Jul 30, 2024 · Completed: Nov 30, 2025
NCT01754311Collaborator
Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1
N/ACompleted
155 participants
Started: May 13, 2013 · Completed: Jun 24, 2014
NCT01205880Collaborator
Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis
PHASE4Completed
12 participants
Started: Dec 31, 2009 · Completed: Jan 31, 2010
Related Companies
Altasciences
acquired